Genmab A/S (GNMSF)
338.98
+9.73
(+2.96%)
USD |
OTCM |
Sep 15, 16:00
Genmab Price : 338.98 for Sept. 15, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | 336.25 | 338.98 | 336.25 | 338.98 | 205.00 |
| Sep 14, 2026 | 329.25 | 329.25 | 329.25 | 329.25 | 0.000 |
| Sep 11, 2026 | 329.25 | 329.25 | 329.25 | 329.25 | 0.000 |
| Sep 10, 2026 | 329.25 | 329.25 | 329.25 | 329.25 | 0.000 |
| Sep 09, 2026 | 329.25 | 329.25 | 329.25 | 329.25 | 0.000 |
| Sep 08, 2026 | 329.25 | 329.25 | 329.25 | 329.25 | 0.000 |
| Sep 04, 2026 | 329.25 | 329.25 | 329.25 | 329.25 | 6.000 |
| Sep 03, 2026 | 338.00 | 338.00 | 338.00 | 338.00 | 0.000 |
| Sep 02, 2026 | 338.00 | 338.00 | 338.00 | 338.00 | 20000.00 |
| Sep 01, 2026 | 338.00 | 338.00 | 338.00 | 338.00 | 0.000 |
| Aug 31, 2026 | 338.00 | 338.00 | 338.00 | 338.00 | 0.000 |
| Aug 28, 2026 | 338.00 | 338.00 | 338.00 | 338.00 | 0.000 |
| Aug 27, 2026 | 332.64 | 338.00 | 332.64 | 338.00 | 24.00 |
| Aug 26, 2026 | 337.00 | 337.00 | 337.00 | 337.00 | 0.000 |
| Aug 25, 2026 | 337.00 | 337.00 | 337.00 | 337.00 | 30.00 |
| Aug 24, 2026 | 327.70 | 327.70 | 327.70 | 327.70 | 8.000 |
| Aug 21, 2026 | 337.00 | 337.00 | 337.00 | 337.00 | 288.00 |
| Aug 20, 2026 | 335.00 | 335.00 | 335.00 | 335.00 | 40040.00 |
| Aug 19, 2026 | 320.00 | 320.00 | 320.00 | 320.00 | 0.000 |
| Aug 18, 2026 | 320.00 | 320.00 | 320.00 | 320.00 | 147.00 |
| Aug 17, 2026 | 320.00 | 320.00 | 320.00 | 320.00 | 4952.00 |
| Aug 14, 2026 | 310.62 | 310.62 | 310.62 | 310.62 | 0.000 |
| Aug 13, 2026 | 310.62 | 310.62 | 310.62 | 310.62 | 29.00 |
| Aug 12, 2026 | 311.51 | 311.51 | 311.51 | 311.51 | 0.000 |
| Aug 11, 2026 | 311.51 | 311.51 | 311.51 | 311.51 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ascendis Pharma A/S | 245.81 |
| Zealand Pharma A/S | 43.00 |
| Bavarian Nordic A/S | 10.44 |
| Evaxion AS | 3.16 |
| ACADIA Pharmaceuticals, Inc. | 27.30 |
Price Related Metrics
| PE Ratio | 26.77 |
| PS Ratio | 5.229 |
| Price to Book Value | 3.397 |
| Price to Free Cash Flow | 24.25 |
| Earnings Yield | 3.74% |
| Market Cap | 20.24B |
| Operating PE Ratio | 16.19 |
| Normalized PE Ratio | 21.95 |